The Latest Breaking News from Dementia

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

Patients unlikely to receive lecanemab before 2026 and health service does not yet have necessary infrastructure

Clinical results suggest that the disease progression can by slowed by 27%

Lecanemab was found to slow decline in patients’ memory and thinking.

‘This is the first drug that provides a real treatment option,’ says leading researcher

Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain

Gorgi Talevski did not live long enough to see his case argued before the U.S. Supreme Court this month. A Macedonian-born resident of Indiana, Talevski operated a crane for three decades, raised a family and loved to dance before his dementia deepened, and he died last year.

The SFA have brought in new guidance to limit the amount of heading in training after research found footballers were more likely to suffer from brain disease in later life.

The Manchester United powerhouse is now bedridden and unable to communicate after being diagnosed with vascular dementia last year.